AI assistant
VERACYTE, INC. — Director's Dealing 2018
Nov 1, 2018
31551_dirs_2018-11-01_c1f5627c-fcb5-4932-9299-bfdfe7539674.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2018-10-31
Reporting Person: Hall Christopher M (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-31 | Common Stock | M | 3500 | $2.36 | Acquired | 35955 | Direct |
| 2018-10-31 | Common Stock | S | 3500 | $13 | Disposed | 32455 | Direct |
| 2018-10-31 | Common Stock | M | 16927 | $2.68 | Acquired | 49382 | Direct |
| 2018-10-31 | Common Stock | S | 16500 | $13.0164 | Disposed | 32882 | Direct |
| 2018-10-31 | Common Stock | S | 427 | $14 | Disposed | 32455 | Direct |
| 2018-10-31 | Common Stock | M | 19573 | $2.68 | Acquired | 52028 | Direct |
| 2018-10-31 | Common Stock | S | 19573 | $14 | Disposed | 32455 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-10-31 | Stock Option (right to buy) | $2.36 | M | 3500 | Acquired | 2021-02-22 | Common Stock (3500.0) | Direct |
| 2018-10-31 | Stock Option (right to buy) | $2.68 | M | 16927 | Acquired | 2022-03-09 | Common Stock (16927.0) | Direct |
| 2018-10-31 | Stock Option (right to buy) | $2.68 | M | 19573 | Acquired | 2022-03-09 | Common Stock (19573.0) | Direct |
Footnotes
F1: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
F2: Represents the aggregate of sales effected on the same day at different prices.
F3: Represents weighted average sales price. Sale prices for the transactions range from $13.00 to $13.08. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4: The option became exercisable upon the grant date.
F5: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.